- Home
- IMRN vs ADN Comparison
IMRN vs ADN Comparison
Compare IMRN & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- ADN
- Stock Information
- Founded
- IMRN 1994
- ADN 2006
- Country
- IMRN Australia
- ADN United States
- Employees
- IMRN N/A
- ADN N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- IMRN Health Care
- ADN Utilities
- Exchange
- IMRN Nasdaq
- ADN Nasdaq
- Market Cap
- IMRN 15.0M
- ADN 8.5M
- IPO Year
- IMRN N/A
- ADN N/A
- Fundamental
- Price
- IMRN $1.97
- ADN $1.75
- Analyst Decision
- IMRN Strong Buy
- ADN
- Analyst Count
- IMRN 1
- ADN 0
- Target Price
- IMRN $5.00
- ADN N/A
- AVG Volume (30 Days)
- IMRN 11.5K
- ADN 31.5K
- Earning Date
- IMRN 10-29-2024
- ADN 10-15-2024
- Dividend Yield
- IMRN N/A
- ADN N/A
- EPS Growth
- IMRN N/A
- ADN N/A
- EPS
- IMRN N/A
- ADN N/A
- Revenue
- IMRN $3,271,194.00
- ADN $7,026,000.00
- Revenue This Year
- IMRN N/A
- ADN $2,232.99
- Revenue Next Year
- IMRN N/A
- ADN $91.56
- P/E Ratio
- IMRN N/A
- ADN N/A
- Revenue Growth
- IMRN 171.67
- ADN 9.01
- 52 Week Low
- IMRN $1.48
- ADN $1.71
- 52 Week High
- IMRN $5.96
- ADN $18.90
- Technical
- Relative Strength Index (RSI)
- IMRN 30.02
- ADN 37.69
- Support Level
- IMRN $1.80
- ADN $1.79
- Resistance Level
- IMRN $2.28
- ADN $1.99
- Average True Range (ATR)
- IMRN 0.20
- ADN 0.17
- MACD
- IMRN -0.07
- ADN 0.01
- Stochastic Oscillator
- IMRN 15.93
- ADN 7.02
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.